Date post: | 19-Dec-2015 |
Category: |
Documents |
View: | 212 times |
Download: | 0 times |
The InterAct Project
Dr Claudia Langenberg, MRC Epidemiology Unit, Cambridge
14th of February 2011,
Institute of Public Health
The InterAct Project
An Examination of the Interaction of Genetic and Lifestyle Factors on the Incidence of Type 2 Diabetes
Objectives• To discover how genetic and lifestyle behavioral factors,
particularly diet and physical activity, interact in their influence on the risk of developing type 2 diabetes.• EPIC nested case-cohort study
• To investigate how these discoveries may help to prevent the development of diabetes. • Lifestyle intervention studies
InterAct Research Lines
• RL1 Analysis of gene-lifestyle interaction in observational studies of diabetes incidence
• RL2 Analysis of nutritional factors and physical activity in observational studies of diabetes incidence
• RL3 Analysis of genetic factors in observational studies of diabetes incidence
• RL4 Analysis of gene-lifestyle interaction in intervention studies
InterAct Participants
• European, nested case-cohort study of 12,403 cases of incident type 2 diabetes and a subcohort of 15,376 participants conducted in 26 (21) centres in 8 European countries.
• Ascertainment and exclusion of all prevalent cases.
• Ascertainment and verification of T2D cases.
• Selection on a random subcohort (proportionate to T2D incidence and oversampled for prevalence).
InterAct Cases & Subcohort
EPIC Europe:5.42 million person-years
(n=455,680)
InterAct Denominator:3.99 million person-years
(340,234)
Random subcohort:16,835
Exclusions: 681Prevalent diabetes (548), post-
censoring diabetes (4), unknown status (129)
Exclusions:No stored buffy coat/ blood
(109,625) or no diabetes status reported (5,821)
Ascertained T2D cases: 17,928(17,407 from ascertainment, 521
identified in verification)
Random subcohort (post exclusions):
16,154
Verified incident T2D cases:12,403
Exclusions: 5,525Denmark (2,577), not diabetic
(838), prevalent diabetes (421), post-censoring diabetes (101),
unknown status (1,588)
Overlap: 778 verified incident T2D cases
HRs for T2D per 1 SD difference in waist and BMI
Overall
Centre
Potsdam
Netherlands
Turin
Navarra
Granada
Bilthoven
Sweden
Subtotal
Subtotal
Asturias
Subtotal
Oxford
Umea
Subtotal
Malmo
Cambridge
UK
Italy
Spain
Denmark
Subtotal
Florence
Copenhagen
Subtotal
Germany
San Sebastian
Subtotal
Murcia
Aarhus
Varese
Heidelberg
Ragusa
1.93 (1.82, 2.05)
Ratio (95% CI)
2.05 (1.69, 2.50)
Hazard
2.02 (1.62, 2.51)
1.57 (1.34, 1.85)
1.86 (1.33, 2.61)
1.81 (1.40, 2.35)
1.92 (1.48, 2.49)
1.89 (1.70, 2.10)
2.15 (1.77, 2.63)
2.22 (1.93, 2.57)
2.25 (1.72, 2.95)
1.68 (1.47, 1.93)
2.18 (1.89, 2.52)
2.19 (1.92, 2.51)
2.21 (1.87, 2.62)
1.76 (1.56, 1.99)
1.91 (1.41, 2.61)
1.87 (1.65, 2.12)
1.81 (1.40, 2.35)
1.83 (1.48, 2.25)
1.98 (1.73, 2.28)
1.59 (1.35, 1.89)
1.93 (1.59, 2.36)
1.74 (1.24, 2.44)
2.33 (1.89, 2.88)
2.17 (1.63, 2.89)
1.93 (1.82, 2.05)
Ratio (95% CI)
2.05 (1.69, 2.50)
Hazard
2.02 (1.62, 2.51)
1.57 (1.34, 1.85)
1.86 (1.33, 2.61)
1.81 (1.40, 2.35)
1.92 (1.48, 2.49)
1.89 (1.70, 2.10)
2.15 (1.77, 2.63)
2.22 (1.93, 2.57)
2.25 (1.72, 2.95)
1.68 (1.47, 1.93)
2.18 (1.89, 2.52)
2.19 (1.92, 2.51)
2.21 (1.87, 2.62)
1.76 (1.56, 1.99)
1.91 (1.41, 2.61)
1.87 (1.65, 2.12)
1.81 (1.40, 2.35)
1.83 (1.48, 2.25)
1.98 (1.73, 2.28)
1.59 (1.35, 1.89)
1.93 (1.59, 2.36)
1.74 (1.24, 2.44)
2.33 (1.89, 2.88)
2.17 (1.63, 2.89)
11 2 5
BMI (z scores)
Overall
Copenhagen
Denmark
Centre
Asturias
Subtotal
Granada
Sweden
Subtotal
Varese
Subtotal
Cambridge
Netherlands
Subtotal
Ragusa
UK
Florence
Oxford
Spain
Aarhus
Malmo
Turin
San Sebastian
Murcia
Bilthoven
Subtotal
Navarra
Germany
Potsdam
Subtotal
Heidelberg
Subtotal
Italy
1.95 (1.83, 2.08)
1.97 (1.74, 2.22)
Ratio (95% CI)
2.21 (1.80, 2.73)
1.95 (1.76, 2.17)
1.98 (1.34, 2.94)
2.11 (1.84, 2.42)
1.78 (1.22, 2.59)
1.80 (1.57, 2.07)
2.25 (1.84, 2.76)
2.28 (1.99, 2.61)
2.38 (1.72, 3.29)
2.04 (1.47, 2.83)
1.63 (1.27, 2.08)
1.92 (1.58, 2.34)
1.69 (1.42, 2.02)
2.14 (1.76, 2.59)
1.81 (1.42, 2.30)
1.52 (1.20, 1.92)
1.87 (1.50, 2.33)
1.69 (1.42, 2.02)
1.65 (1.37, 1.97)
2.29 (1.87, 2.80)
1.87 (1.50, 2.33)
2.27 (1.88, 2.73)
1.93 (1.41, 2.66)
Hazard
1.95 (1.83, 2.08)
1.97 (1.74, 2.22)
Ratio (95% CI)
2.21 (1.80, 2.73)
1.95 (1.76, 2.17)
1.98 (1.34, 2.94)
2.11 (1.84, 2.42)
1.78 (1.22, 2.59)
1.80 (1.57, 2.07)
2.25 (1.84, 2.76)
2.28 (1.99, 2.61)
2.38 (1.72, 3.29)
2.04 (1.47, 2.83)
1.63 (1.27, 2.08)
1.92 (1.58, 2.34)
1.69 (1.42, 2.02)
2.14 (1.76, 2.59)
1.81 (1.42, 2.30)
1.52 (1.20, 1.92)
1.87 (1.50, 2.33)
1.69 (1.42, 2.02)
1.65 (1.37, 1.97)
2.29 (1.87, 2.80)
1.87 (1.50, 2.33)
2.27 (1.88, 2.73)
1.93 (1.41, 2.66)
Hazard
11 2 5
Waist (z scores)
Men
Cumulative risk of T2D in the subcohort by sex, BMI and waist groups
0.00
0.05
0.10
0.15
0.20
0.25
0 5 10 15
BMI < 25 kg/m2
0 5 10 15
BMI 25-29.9 kg/m2
0 5 10 15
BMI >=30 kg/m2
Cu
mu
lativ
e r
isk
of
dia
bete
s
Time since study entry (years)
Men
___ Waist <94cm in men/ 80cm in women ___ Waist ≥94-101.9cm in men/ 80-87.9cm in women ___ Waist ≥102cm in men/ 88cm in women
Main effects iPLEX1 (n=21,178; 9,233 cases/ 11,945 random controls)
Adjusted for sex, centre Adjusted for sex, latitude and longitude of the centre
Adjusted for sex, centre and BMI
Gene SNP HR T2D 95% CI p-value HR T2D* 95% CI* p-value* HR T2D* 95% CI* p-value* SLC30A8 rs13266634 1.13 1.07-1.20 1.06E-05 1.13 1.07-1.20 6.67E-06 1.13 1.04-1.22 0.002 KCNJ11 proxy rs757110 1.06 1.01-1.10 0.008 1.06 1.01-1.10 0.008 1.09 1.03-1.14 0.001 TSPAN8 rs7961581 1.05 1.00-1.10 0.035 1.05 1.00-1.10 0.036 1.08 1.02-1.14 0.007 CDKN2A/B rs564398 1.02 0.94-1.11 0.612 1.02 0.94-1.10 0.625 1.05 0.95-1.16 0.319 INS1 rs689 1.03 0.97-1.08 0.340 1.03 0.97-1.08 0.329 1.04 0.97-1.12 0.219 PPARg rs1801282 1.05 0.94-1.17 0.362 1.05 0.94-1.17 0.358 1.09 0.98-1.20 0.102 HHEX rs1111875 1.11 1.01-1.21 0.030 1.11 1.01-1.21 0.028 1.13 1.02-1.25 0.018 KCNQ1 rs2237892 1.07 0.90-1.27 0.455 1.07 0.90-1.26 0.458 1.06 0.87-1.28 0.582 NOTCH2 rs10923931 1.09 0.94-1.28 0.263 1.09 0.94-1.27 0.266 1.15 0.96-1.37 0.123 THADA rs7578597 1.11 0.98-1.26 0.103 1.11 0.98-1.26 0.101 1.16 1.03-1.32 0.016 MTNR1B rs10830963 1.07 1.01-1.13 0.021 1.07 1.01-1.13 0.020 1.06 0.98-1.15 0.161 CDC123 rs12779790 1.05 1.00-1.11 0.049 1.05 1.00-1.11 0.050 1.03 0.95-1.12 0.516 CDKN2A/B rs10811661 1.13 1.07-1.19 4.50E-06 1.13 1.07-1.19 3.50E-06 1.19 1.11-1.28 6.59E-07 JAZF1 rs864745 1.08 1.03-1.12 3.16E-04 1.08 1.03-1.12 3.43E-04 1.12 1.07-1.18 3.57E-06 ADAMTS9 rs4607103 0.97 0.92-1.02 0.275 0.97 0.92-1.02 0.276 0.99 0.92-1.06 0.687 CDKAL1 rs10946398 1.12 1.07-1.17 6.03E-07 1.12 1.07-1.17 7.03E-07 1.14 1.06-1.22 0.001 Genetic score 1.08 1.06-1.09 4.01E-31 1.08 1.06-1.09 3.52E-31 1.10 1.08-1.12 2.91E-30 G6PC2 rs563694 0.99 0.95-1.03 0.712 0.99 0.95-1.04 0.718 0.99 0.94-1.04 0.624 ETV5 rs7647305 1.00 0.96-1.06 0.849 1.00 0.96-1.06 0.850 0.97 0.92-1.04 0.396 MC4R rs17782313 1.04 0.97-1.10 0.266 1.04 0.98-1.10 0.249 1.00 0.91-1.11 0.966
www.inter-act.eu
Acknowledgements